Evidence map›Paper›PMID 21875954›Full record

ArticleThe Journal of experimental medicine2011

WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity.

Shirly Becker-Herman, Almut Meyer-Bahlburg, Marc A Schwartz, Shaun W Jackson, Kelly L Hudkins, Chaohong Liu, Blythe D Sather, Socheath Khim, Denny Liggitt, Wenxia Song and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 156 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Shirly Becker-HermanDepartment of Pediatrics, University of Washington School of Medicine, Seattle, WA; Seattle Children’s Research Institute, Seattle, WA, USA.
Almut Meyer-Bahlburg
Marc A Schwartz
Shaun W Jackson
Kelly L Hudkins
Chaohong Liu
Blythe D Sather
Socheath Khim
Denny Liggitt
Wenxia Song
Gregg J Silverman
Charles E Alpers
David J Rawlings
University of Washington · USPediatrics and Genetics · USUniversity of Maryland, College Park · USUniversity of California, San Diego · US

Funding

RESEARCH TRAINING IN RHEUMATOLOGYT32AR007108 · NIAMS · UNIVERSITY OF WASHINGTON · PI Shaun Jackson, Tomas M Mustelin · 1986 to 2026
$6.6M
MMPC: Diabetes and Diabectic ComplicationsU24DK076126 · NIDDK · UNIVERSITY OF WASHINGTON · PI LEBOEUF, RENEE C · 2006 to 2010
$4.8M
Lentiviral Gene Therapy for Wiskott-Aldrich SyndromeR01AI071163 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2008 to 2012
$3.5M
REGULATION OF B CELL DEVELOPMENT AND SIGNALING BY BTKR01HD037091 · NICHD · UNIVERSITY OF WASHINGTON · PI RAWLINGS, DAVID J · 1999 to 2008
$2.7M
B CELL SUPERANTIGENS AND IMMUNE REGULATIONR01AI040305 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 1998 to 2008
$2.4M
Lentiviral Gene Therapy for Wiskott-Aldrich SyndromeR56AI071163 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAWLINGS, DAVID J · 2007 to 2007
$615k
ENGINEERED B-CELL SUPERANTIGENS AND IMMUNE TOLERANCER03AI046637 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 1999 to 2001
$152k
NIAID NIH HHS AI071163NIAID NIH HHS AI40305NIAID NIH HHS AI46637NIAID NIH HHS R01 AI040305NIAID NIH HHS R01 AI071163NIAID NIH HHS R56 AI071163NIAMS NIH HHS 5T32AR007108-32NIAMS NIH HHS T32 AR007108NICHD NIH HHS HD037091NICHD NIH HHS R01 HD037091NIDDK NIH HHS DK76126NIDDK NIH HHS U24 DK076126
6 · The paper itself

Abstract

Patients with the immunodeficiency Wiskott-Aldrich syndrome (WAS) frequently develop systemic autoimmunity. Here, we demonstrate that mutation of the WAS gene results in B cells that are hyperresponsive to B cell receptor and Toll-like receptor (TLR) signals in vitro, thereby promoting a B cell-intrinsic break in tolerance. Whereas this defect leads to autoantibody production in WAS protein-deficient (WASp(-/-)) mice without overt disease, chimeric mice in which only the B cell lineage lacks WASp exhibit severe autoimmunity characterized by spontaneous germinal center formation, class-switched autoantibodies, renal histopathology, and early mortality. Both T cell help and B cell-intrinsic TLR engagement play important roles in promoting disease in this model, as depletion with anti-CD4 antibodies or generation of chimeric mice with B cells deficient in both WASp and MyD88 prevented development of autoimmune disease. These data highlight the potentially harmful role for cell-intrinsic loss of B cell tolerance in the setting of normal T cell function, and may explain why WAS patients with mixed chimerism after stem cell transplantation often develop severe humoral autoimmunity.

Indexed as

AnimalsAntibodies, AntinuclearAutoantibodiesAutoimmunityB-LymphocytesCD4-Positive T-LymphocytesChimeraFemaleHumansMiceMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88Receptors, Antigen, B-CellToll-Like ReceptorsWiskott-Aldrich Syndrome ProteinAntibodies, AntinuclearAutoantibodiesMyd88 protein, mouseMyeloid Differentiation Factor 88Receptors, Antigen, B-CellToll-Like ReceptorsWiskott-Aldrich Syndrome Protein

Identifiers

PMID21875954
PMCPMC3182055
OpenAlexW2165006836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.